Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine Oral Gel Pharmacokinetics in Healthy Adults
NCT05164367Phase 1Completed
- Sponsor
- University of Utah
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atropine in sialorrhea, sponsored by University of Utah. Primary endpoints: Time to Maximum Plasma Concentration at 24 hours, Maximum Plasma Concentration at 24 hours and 3 more. Started Oct 2022; status: completed.
02
Drugs
atropine
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT05164367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05164367.